Ventyx Biosciences Inc. (NASDAQ: VTYX) jumped 86.53% to $7.20 in after-hours trading on Wednesday after the company reported ...

The San Diego-based biotech has been evaluating the oral NLRP3 inhibitor, dubbed VTX3232, in a phase 2 study of 175 patients ...

Ventyx Biosciences, Inc. surged after strong Phase 2 results for VTX3232 in obesity. Click for key insights and what VTYX ...

Phages are particularly advantageous anti-infectives as they are novel therapeutics, can target antibiotic-resistant bacteria ...

Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory ...

Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that defines specific depression subtypes and influences how patients respond ...

With more cultivation, legalization, and use of cannabis, it's become apparent that some users and others exposed to fumes or ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused ...

A new study from the University of South Australia has found that having low levels of vitamin D in your body may lead to ...

Ulcerative colitis that remains untreated (or undertreated) for too long can cause serious complications that can have long-term effects.

Cosmic beings, the sky is still rippling with the emotional, existential echoes of last week’s Jupiter–Chiron square, and ...